Homozygous sickle cell disease in patients above 20 years of age: Follow-up of 108 patients in Dakar;La drépanocytose homozygote après l'âge de 20 ans: Suivi d'une cohorte de 108 patients au CHU de Dakar

Revue de Medecine Interne

Volumn 24, Issue 11, 2003, Pages 711-715

  Diop, S ^a   Mokono, S O ^a   Ndiaye, M ^a   Toure Fall A O ^a   Thiam, D ^a   Diakhate L ^a  

^a Centre Hospitalier Universitaire Dakar   (Senegal)

Author keywords

Africa; Anemia; Hemoglobinopathy; Sickle cell anemia

Indexed keywords

ADULT; AFRICA; ARTICLE; BLOOD TRANSFUSION; BLOOD VESSEL OCCLUSION; DEVELOPED COUNTRY; EDUCATION; EYE DISEASE; FEMALE; FEMUR HEAD NECROSIS; FOLLOW UP; GALLSTONE; HEART DISEASE; HOMOZYGOSITY; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; LEG ULCER; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIAPISM; SENEGAL; SEX DIFFERENCE; SICKLE CELL ANEMIA; SOCIAL ASPECT;

EID: 0242680312     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(03)00220-0     Document Type: Article

References (17)

1. Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G. Improved survival in homozygous sickle cell disease: lessons from a cohort study. Br Med J 1995;311:1600-2.
2. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg Klug PP. Mortality in sickle cell disease. Life expectancy and risk factor for early death. N Engl J Med 1994;330:1639-44.
3. Nagel RL, Erlingsson S, Fabry ME, Croizat H, Susuka SM, Lachman H, et al. The Senegal DNA haplotype is associated with the amelioration of anemia in African-American sickle cell anemia patients. Blood 1991;77:1371-5.
4. Diop S, Cisse M, Touré Fall AO, Thiam D, Fall K, Gadji M, et al. La drépanocytose homozygote à Dakar: influence du taux d'Hb F, des facteurs socioculturels et économiques. Dakar Méd 1999;44:171-4.
5. Diop S, Thiam D, Cisse M, Touré Fall AO, Fall K, Diakhaté L. New results in clinical severity of homozygous sickle cell anemia in Dakar, Senegal. Hematol Cell Ther 1999;41:217-21.
6. Godeau B, Noël V, Habibi A, Schaeffer A, Bachir D, Galacteros F. La drépanocytose chez l'adulte: quelles urgences chez l'interniste? Rev Med Interne 2001;22:440-51.
7. Diagne I, Ndiaye O, Moreira C, Signaté Sy H, Camara B, Diouf S, et al. Les syndromes drépanocytaires majeurs en pédiatrie à Dakar (Sénégal). Arch Pediatr 2000;7:16-24.
8. Wierenga KJ, Hambleton IR, Lewis NA. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet 2001;357:680-3.
9. Jardin F, Sane M, Cloatre G, Thiam M, Camara P, Pouplin S, et al. L'adulte drépanocytaire au Sénégal. Étude clinique de 40 sujets homozygotes. Med Trop 1999;59:271-5.
10. Yetunde A, Anyaegbu CC. Profile of the Nigerian sickle cell anemia patients above 30 years of age. Cent Afr J Med 2001;47:108-11.
11. Kotilla TR, Shokunbi WA. Survival advantage in female patients with sickle cell anemia. East Afr J Med 2001;78:373-5.
12. Miller ST, Sleeper LA, Pegelow CH, Enos LE, Wang WC, Weiner DL, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000;342:1612-3.
13. Godeau B, Brun-Buisson C, Roudot-Thoraval F, Ruivard M, Durègne L, Lefort Y, et al. Évolution et facteurs pronostiques des adultes atteints d'un syndrome drépanocytaire majeur lors de leur admission en réanimation. Rev Med Interne 1999;20(suppl 6):587.
14. Perronne V, Roberts-Harewood M, Bachir D, Roudot-Thorval F, Debord JM, Thuret I, et al. Patterns of mortality in sickle cell disease in adults in France and England. Hematol J 2002;3:56-60.
15. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, et al. Pain in sickle cell disease. N Engl J Med 1991;325:11-6.
16. Charache S, Terrin M, Moore R, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-22.
17. Powars D, Hiti A. Sickle cell anemia: Beta S gene cluster Haplotype as genetic markers for severe disease expression. AJDC 1993;147:1197-202.